From: Sedation in non-invasive ventilation: do we know what to do (and why)?
Study | No. of patients | Indication | NIV interface | Type of sedative | Initiation of sedation |
---|---|---|---|---|---|
Rocker et al. [10] | 10 | ARF | FFM | Morphine | At start of NIV |
Constantin et al. [11] | 13 | ARF (n = 10); AHRF (n = 3) | FFM | Remifentanil, midazolam* | Poor NIV acceptance |
Rocco et al. [12] | 36 | ARF | FFM, helmet | Remifentanil | Poor NIV acceptance |
Akada et al. [13] | 10 | ARF | FFM | Dexmedetomidine†| Poor NIV acceptance |
Takasaki et al. [14] | 2 | SAA | FFM | Dexmedetomidine | Poor NIV acceptance |
Clouzeau et al. [15] | 10 | ARF (n = 7); AHRF (n = 3) | FFM | Propofol | Poor NIV acceptance |
Senoglu et al. [16] | 40 | COPD | FFM | Dexmedetomidine (n = 20); midazolam (n = 20) | At start of NIV |
Huang et al. [17] | 62 | ACPO | FFM, helmet | Dexmedetomidine (n = 33); midazolam (n = 29) | Poor NIV acceptance |